All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @modernbodyclinic on TikTok · 47s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @modernbodyclinic's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00It doesn't necessarily happen from taking these medications.
  2. 0:03Typically it's a lack of nutrition.
  3. 0:06One, you're eating enough protein in the day.
  4. 0:08An average adult needs between 60 and 90 grams a day.
  5. 0:12Again, it depends.
  6. 0:13Are you male, female?
  7. 0:14So seek medical advice for that specifically.
  8. 0:17Another thing that I recommend is vitamin D3 with K2.
  9. 0:21The K2 assists with the absorption of the vitamin D3.
  10. 0:24So make sure that it does have that in your supplement.
  11. 0:28Third thing I recommend is a greens powder.
  12. 0:31That just kind of gives you insurance
  13. 0:33to make sure that you're getting enough vegetables in the day.
  14. 0:36Oftentimes we're so busy, we barely have time to eat.
  15. 0:40So making sure you're having enough greens in the day.
  16. 0:43Check out below and I'll give you
  17. 0:45a couple of my recommendations.

TikTok clinic's peptide hair loss supplements, fact-checked

Modern Body Clinic | AZ

TikTok creator

74.8K viewsWatch on TikTok

Quick answer

Hair loss reported during GLP-1 receptor agonist therapy (semaglutide, tirzepatide) is most commonly attributed to telogen effluvium secondary to rapid caloric restriction and weight loss, not direct pharmacological toxicity. Nutritional support, particularly adequate dietary protein, is a reasonable and clinically supported mitigation strategy, though it does not eliminate the side effect in all patients. Vitamin D deficiency is prevalent in patients with obesity and worth screening for, but supplementation should follow lab-based assessment rather than assumption.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For TikTok clinic's peptide hair loss supplements, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

TikTok clinic's peptide hair loss supplements, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "TikTok clinic's peptide hair loss supplements, fact-checked" from Modern Body Clinic | AZ. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Hair loss reported during GLP-1 receptor agonist therapy (semaglutide, tirzepatide) is most commonly attributed to telogen effluvium secondary to rapid caloric restriction and weight loss, not direct pharmacological toxicity.

The reason this review is not generic is the source wording and the canonical claim label "trt having hairloss on peptides here are supplement recommendat." In this clip, the useful excerpt is: "It doesn't necessarily happen from taking these medications." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Protein intake of 60-90g daily reflects the general population RDA, but patients on weight-loss medications may need closer to 1.
People who land here are usually comparing the Testosterone claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Testosterone guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Hair loss reported during GLP-1 receptor agonist therapy (semaglutide, tirzepatide) is most commonly attributed to telogen effluvium secondary to rapid caloric restriction and weight loss, not direct pharmacological toxicity.

FormBlends verdict

Testosterone evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Hair loss reported during GLP-1 receptor agonist therapy (semaglutide, tirzepatide) is most commonly attributed to telogen effluvium secondary to rapid caloric restriction and weight loss, not direct pharmacological toxicity. Nutritional support, particularly adequate dietary protein, is a reasonable and clinically supported mitigation strategy, though it does not eliminate the side effect in all patients. Vitamin D deficiency is prevalent in patients with obesity and worth screening for, but supplementation should follow lab-based assessment rather than assumption.
  • Telogen effluvium from rapid weight loss is a recognized side effect of GLP-1 therapy, not simply a nutrition oversight, per FDA adverse event data and clinical literature.
  • Protein intake of 60-90g daily reflects the general population RDA, but patients on weight-loss medications may need closer to 1.2-1.6g per kilogram of body weight to preserve lean mass.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Telogen effluvium from rapid weight loss is a recognized side effect of GLP-1 therapy, not simply a nutrition oversight, per FDA adverse event data and clinical literature.
  • Protein intake of 60-90g daily reflects the general population RDA, but patients on weight-loss medications may need closer to 1.2-1.6g per kilogram of body weight to preserve lean mass.
  • Vitamin D3 and K2 interact in calcium metabolism pathways, not in D3 absorption directly. Testing vitamin D levels before supplementing is more appropriate than assuming deficiency.
  • Rushton (2002, Journal of Dermatology) linked dietary protein insufficiency to hair follicle cycle disruption, supporting the creator's protein recommendation on biological grounds.
  • Distributing protein intake across multiple meals is more effective for muscle and tissue support than consuming it in a single sitting, per Paddon-Jones et al. (2009, American Journal of Clinical Nutrition).
  • Greens powders have no clinical evidence base for treating or preventing drug-associated hair loss. They may support general micronutrient intake but should not be sold as a hair loss solution.
  • Hair loss with new symptoms like fatigue, cold intolerance, or brittle nails warrants thyroid and iron testing before attributing it to GLP-1 medication or diet.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @modernbodyclinic actually say?

The creator's core argument is that hair loss associated with GLP-1 medications like semaglutide and tirzepatide "doesn't necessarily happen from taking these medications" but is instead caused by nutritional gaps, specifically low protein, vitamin D deficiency, and insufficient vegetable intake. They recommend protein powder, a D3+K2 supplement, and a greens powder to address it. The framing is cautious, not alarmist, which is a point in their favor.

They correctly note that protein needs vary by sex and body composition, advising viewers to "seek medical advice for that specifically." That disclaimer matters. The supplement recommendations are brand-specific, which raises commercial conflict-of-interest questions the video doesn't address.

Does the science back this up?

Partially, but the creator oversimplifies a more complicated picture. Hair loss during GLP-1 therapy is real and documented. A 2023 FDA adverse event analysis flagged alopecia as a reported side effect of semaglutide. The mechanism most supported by evidence is telogen effluvium, a stress-related shedding triggered by rapid caloric restriction and significant weight loss, not necessarily the drug itself.

Protein deficiency can absolutely drive telogen effluvium. Research by Rushton (2002, Journal of Dermatology) linked inadequate dietary protein to hair follicle cycling disruption. The 60-90 gram daily protein target the creator cites is a reasonable approximation of the RDA range, though clinical guidelines for patients on GLP-1 therapy often push higher, toward 1.2-1.6g per kilogram of body weight, per Bariatric Surgery practice guidelines. Vitamin D deficiency has an association with alopecia areata specifically (Rasheed et al., 2013, Saudi Medical Journal), though evidence connecting it to telogen effluvium is weaker and more correlational than causal.

What did they get wrong or right?

They got the protein angle largely right. Patients on GLP-1 medications frequently undereat protein because appetite suppression reduces overall food intake, and if they're not intentional about protein-dense foods, deficiency follows. The hair loss connection here is biologically plausible and reasonably well-supported.

Where they go wrong is the framing that hair loss "doesn't necessarily happen from taking these medications." That hedge is doing a lot of work. Telogen effluvium triggered by rapid weight loss is a known, documented consequence of the metabolic change these drugs cause. Saying it's "just nutrition" risks dismissing a legitimate side effect that some patients experience regardless of how well they eat. The vitamin D recommendation is the weakest link here. Claiming K2 "assists with absorption of vitamin D3" is a common supplement-industry talking point, but the research is more nuanced. K2 works synergistically with D3 for calcium metabolism and bone health (Vermeer, 2012, Annals of the New York Academy of Sciences), not specifically bioavailability of D3 itself. That's a meaningful distinction the creator blurs.

What should you actually know?

If you're on a GLP-1 medication and noticing hair shedding, the most evidence-supported approach is ensuring adequate protein intake throughout the day, not just hitting a single number. Research by Paddon-Jones et al. (2009, American Journal of Clinical Nutrition) found distributing protein intake across meals was more effective for muscle protein synthesis than loading it into one meal, which likely extends to hair follicle support as well.

Vitamin D testing before supplementing makes more sense than blanket supplementation. Deficiency is common, especially in patients with obesity, but megadosing without a baseline lab is unnecessary and potentially counterproductive. If you're experiencing significant hair loss on any medication, talk to your prescribing provider before adding a supplement stack. There are conditions like thyroid dysfunction and iron-deficiency anemia that cause similar symptoms and require actual diagnosis, not protein shakes.

  • Telogen effluvium typically resolves within 3-6 months once nutritional status stabilizes.
  • Protein needs on GLP-1 therapy may exceed the general population RDA due to muscle preservation demands.
  • No supplement brand has clinical evidence specific to drug-associated hair loss.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Modern Body Clinic | AZ · TikTok creator

74.8K views on this video

Having hairloss on Peptides? Here are Supplement recommendations: - OWYN Protein Powder or Shakes - Sports Research or MicroIngredients Vitamin D3 + K2 - Live It Up Super Greens #Weightloss #semagl

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about telogen effluvium from rapid weight loss?

Telogen effluvium from rapid weight loss is a recognized side effect of GLP-1 therapy, not simply a nutrition oversight, per FDA adverse event data and clinical literature.

What does the video say about protein intake of 60-90g daily reflects the general population rda,?

Protein intake of 60-90g daily reflects the general population RDA, but patients on weight-loss medications may need closer to 1.2-1.6g per kilogram of body weight to preserve lean mass.

What does the video say about vitamin d3?

Vitamin D3 and K2 interact in calcium metabolism pathways, not in D3 absorption directly. Testing vitamin D levels before supplementing is more appropriate than assuming deficiency.

What does the video say about rushton (2002, journal of dermatology) linked dietary protein insufficiency to?

Rushton (2002, Journal of Dermatology) linked dietary protein insufficiency to hair follicle cycle disruption, supporting the creator's protein recommendation on biological grounds.

What does the video say about distributing protein intake across multiple meals?

Distributing protein intake across multiple meals is more effective for muscle and tissue support than consuming it in a single sitting, per Paddon-Jones et al. (2009, American Journal of Clinical Nutrition).

What does the video say about greens powders have no clinical evidence base for treating?

Greens powders have no clinical evidence base for treating or preventing drug-associated hair loss. They may support general micronutrient intake but should not be sold as a hair loss solution.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Modern Body Clinic | AZ, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.